Carnival Corporation (CCL) is down 4.8% today. Here is some analysis on what might have caused this price movement.
Analysis: The drop looks tied to renewed pressure on travel and cruise stocks as oil prices moved higher, which can raise expected fuel costs. Investors also may be repositioning after Carnival’s recently completed corporate unification/redomiciliation, which can create short-term technical selling. Separately, cruise-industry health headlines may be weighing on sentiment.
Details:
Sources:
Associated Press, CDC, SEC
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$CCL Insider Trading Activity
$CCL insiders have traded $CCL stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CCL stock by insiders over the last 6 months:
- DAVID BERNSTEIN (CFO & CAO) sold 361,790 shares for an estimated $12,016,891
- SIR JONATHON BAND has made 0 purchases and 2 sales selling 12,000 shares for an estimated $314,265.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CCL Hedge Fund Activity
We have seen 555 institutional investors add shares of $CCL stock to their portfolio, and 460 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AUTO-OWNERS INSURANCE CO removed 19,201,000 shares (-96.7%) from their portfolio in Q1 2026, for an estimated $477,432,864
- NUVEEN, LLC removed 17,934,890 shares (-67.1%) from their portfolio in Q1 2026, for an estimated $445,951,039
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 16,781,623 shares (-99.9%) from their portfolio in Q4 2025, for an estimated $512,510,766
- VIKING GLOBAL INVESTORS LP added 14,061,827 shares (+inf%) to their portfolio in Q4 2025, for an estimated $429,448,196
- BARROW HANLEY MEWHINNEY & STRAUSS LLC removed 6,983,644 shares (-19.3%) from their portfolio in Q4 2025, for an estimated $213,280,487
- HOLOCENE ADVISORS, LP removed 5,919,642 shares (-54.4%) from their portfolio in Q4 2025, for an estimated $180,785,866
- D. E. SHAW & CO., INC. added 5,049,420 shares (+548.1%) to their portfolio in Q4 2025, for an estimated $154,209,286
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CCL Analyst Ratings
Wall Street analysts have issued reports on $CCL in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- TD Cowen issued a "Buy" rating on 01/13/2026
- Argus Research issued a "Buy" rating on 12/22/2025
- Barclays issued a "Overweight" rating on 12/22/2025
- UBS issued a "Buy" rating on 12/18/2025
- Wells Fargo issued a "Overweight" rating on 12/01/2025
To track analyst ratings and price targets for $CCL, check out Quiver Quantitative's $CCL forecast page.
$CCL Price Targets
Multiple analysts have issued price targets for $CCL recently. We have seen 17 analysts offer price targets for $CCL in the last 6 months, with a median target of $35.0.
Here are some recent targets:
- Trey Bowers from Wells Fargo set a target price of $36.0 on 04/15/2026
- Robin Farley from UBS set a target price of $35.0 on 04/13/2026
- Ali Naqvi from HSBC set a target price of $30.1 on 03/30/2026
- Richard Clarke from Bernstein set a target price of $28.7 on 03/30/2026
- James Hardiman from Citigroup set a target price of $35.0 on 03/30/2026
- Ben Chaiken from Mizuho set a target price of $39.0 on 03/27/2026
- Brandt Montour from Barclays set a target price of $36.0 on 03/24/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.